Storage Conditions
-20°C/1 year
Applications
ELISA
WB
Concentration
1 mg/ml
Recomended Dilution
Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
Synthesized acetyl-peptide derived from human TAL1/2 around the acetylation site of K221.
Subcellular Location
Nucleus .
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Human Gen
6886
Observed Band
45kD
Other Name
BHLHA17
BHLHA19
Class A basic helix-loop-helix protein 17
Class A basic helix-loop-helix protein 19
SCL
Stem cell protein
T-cell acute lymphocytic leukemia protein 1
T-cell acute lymphocytic leukemia protein 2
T-cell leukemia/lymphoma protein 5
TAL-1
TAL-2
TAL1
TAL2
TCL5
bHLHa17
bHLHa19
Background
14)(p32
alternative products:The splicing pattern is cell-lineage dependent,disease:A chromosomal aberration involving TAL1 may be a cause of some T-cell acute lymphoblastic leukemias (T-ALL). Translocation t(1
q11) with T-cell receptor alpha chain (TCRA) genes.,domain:The helix-loop-helix domain is necessary and sufficient for the interaction with DRG1.,function:Implicated in the genesis of hemopoietic malignancies. It may play an important role in hemopoietic
subsequent to hypoxia-dependent phosphorylation of Ser-122, ubiquitination targets the protein for rapid degradation via the ubiquitin system. This process may be characteristic for microvascular endothelial cells, since it could not be observed in large